NRC Health Q3 revenue falls 5.5% to $35.8M; EPS drops to $0.24 from $0.32

NRC HEALTH

2024-Q3 EPS reported $0.76 revenue$106,154,000

Revenue $35.8M vs $37.9M a year ago; diluted EPS $0.24 vs $0.32.
Net indebtedness $50.2M at Sept 30, 2024; Total Recurring Contract Value $131.6M.
Returned $11.5M to stockholders: $8.6M share repurchases (395k shares) and $2.9M dividends.
Board declared $0.12 quarterly dividend payable Jan 10, 2025 to holders of record Dec 27, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.